Bora Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Bora Pharmaceuticals has a total shareholder equity of NT$11.8B and total debt of NT$4.1B, which brings its debt-to-equity ratio to 35%. Its total assets and total liabilities are NT$25.1B and NT$13.3B respectively. Bora Pharmaceuticals's EBIT is NT$5.2B making its interest coverage ratio 48.5. It has cash and short-term investments of NT$3.4B.
Key information
35.0%
Debt to equity ratio
NT$4.12b
Debt
Interest coverage ratio | 48.5x |
Cash | NT$3.40b |
Equity | NT$11.77b |
Total liabilities | NT$13.29b |
Total assets | NT$25.05b |
Recent financial health updates
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19Recent updates
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?
Mar 17Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment
Feb 17New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)
Jan 27Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings
Dec 29Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?
Dec 09Financial Position Analysis
Short Term Liabilities: 6472's short term assets (NT$10.6B) exceed its short term liabilities (NT$8.2B).
Long Term Liabilities: 6472's short term assets (NT$10.6B) exceed its long term liabilities (NT$5.1B).
Debt to Equity History and Analysis
Debt Level: 6472's net debt to equity ratio (6.2%) is considered satisfactory.
Reducing Debt: 6472's debt to equity ratio has reduced from 42.1% to 35% over the past 5 years.
Debt Coverage: 6472's debt is well covered by operating cash flow (111.9%).
Interest Coverage: 6472's interest payments on its debt are well covered by EBIT (48.5x coverage).